Physicians’ Prescribing Preferences for the Usage of Anti-Diabetic and Anti-Obesity Medications for Effective Weight Management in Iraq
Journal of Primary Care & Community Health · 2026-11 · 17
DOI: 10.1177/21501319261504064 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Primary Care & Community Health, online erschienen am 18.11.2026. Verfasst von Khansaa A Ibrahim Albaroodi. Beteiligte Einrichtung: Pharmacy College, Al-Zahrawi University, Karbala, Iraq. Hauptthemen laut MEDLINE: Anti-Obesity Agents, Hypoglycemic Agents, Obesity, Practice Patterns, Physicians'. Die Arbeit nennt 32 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).
Abstract (Originalsprache)
Purpose
There is limited data on weight management medications in Iraq; therefore, this pilot study aimed to assess physicians’ prescribing preferences for anti-diabetic and anti-obesity to support effective weight management.
Methods
This pilot study targeted healthcare professionals working in weight-loss clinics in Iraq; participants from four provinces: Karbala, Najaf, Diwaniya, and Hilla were included. Conducted between October 1, 2024, and December 31, 2024. The study used convenience sampling. Results were obtained by using SPSS (version 20).
Results
Among 15 participants aged 44.6±8.3 years (ranging from 29 to 60 years), with 7.6±3.6 years (ranging from 2 to 14 years) of experience in nutrition, approximately 40% preferred either metformin or orlistat. Side effects that restricted medication use were nausea, dizziness, and diarrhea, with 40%, 33.3%, and 20%, respectively. All medication were assessed preference items on a dichotomous (yes/no) scale. No multi-item scale was used; therefore, range-based interpretation is not applicable. Preferences are reported as percentages of participants selecting each medication. No significant associations were observed between medications and comorbidities, except that semaglutide preference was positively associated with consideration of general health factors (Cramér’s V = 1.000, p = 0.0001), indicating a strong effect size despite the small sample. No statistically significant difference in preference frequency was observed between metformin and orlistat (p = 0.132). Preference for semaglutide was not significantly lower than for metformin (p = 0.486, Fisher’s exact test).
Conclusion
This pilot study highlights obesity management and the need for transitioning from a weight-centric model to a comprehensive metabolic health framework. In practical terms, this includes routine comorbidity assessment before prescribing, using GLP-1 agonists for patients with obesity and cardiovascular risk factors, and insurance or subsidy policies to improve access to newer agents. As a pilot study with a small convenience sample (n=15), findings are preliminary and require validation in larger, multi-region Iraqi samples.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Pharmacy College, Al-Zahrawi University, Karbala, Iraq.
ORCID-Profile: Khansaa A Ibrahim Albaroodi
Zitieren
APA
Ibrahim Albaroodi, K. A. (2026). Physicians’ Prescribing Preferences for the Usage of Anti-Diabetic and Anti-Obesity Medications for Effective Weight Management in Iraq. Journal of Primary Care & Community Health, 17. https://doi.org/10.1177/21501319261504064
Vancouver
Ibrahim Albaroodi KA. Physicians’ Prescribing Preferences for the Usage of Anti-Diabetic and Anti-Obesity Medications for Effective Weight Management in Iraq. Journal of Primary Care & Community Health. 2026;17. doi:10.1177/21501319261504064
BibTeX
@article{IbrahimAlbaroodi2026,
author = {Ibrahim Albaroodi, Khansaa A},
title = {Physicians’ Prescribing Preferences for the Usage of Anti-Diabetic and Anti-Obesity Medications for Effective Weight Management in Iraq},
journal = {Journal of Primary Care & Community Health},
year = {2026},
volume = {17},
doi = {10.1177/21501319261504064}
}
EUVIMED